223 related articles for article (PubMed ID: 17235280)
21. HIV and hepatitis C virus coinfection: bad bedfellows.
Schooley RT
Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
[TBL] [Abstract][Full Text] [Related]
22. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
[No Abstract] [Full Text] [Related]
23. Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future.
Shire NJ; Sherman KE
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S63-8. PubMed ID: 16265616
[TBL] [Abstract][Full Text] [Related]
24. Hepatic and renal safety profile of tenofovir in HIV-infected patients with hepatitis C, including patients on interferon plus ribavirin.
Sánchez-Conde M; Gil P; Sánchez-Somolinos M; Gonzalez-Lahoz J; Soriano V
HIV Clin Trials; 2005; 6(5):278-80. PubMed ID: 16306034
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
Sterling RK; Sulkowski MS
Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
[TBL] [Abstract][Full Text] [Related]
26. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
[No Abstract] [Full Text] [Related]
27. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office.
Tien PC; ;
Am J Gastroenterol; 2005 Oct; 100(10):2338-54. PubMed ID: 16181388
[TBL] [Abstract][Full Text] [Related]
28. New paradigms in the management of HIV and hepatitis C virus coinfection.
Soriano V; Martin-Carbonero L; Maida I; Garcia-Samaniego J; Nuñez M
Curr Opin Infect Dis; 2005 Dec; 18(6):550-60. PubMed ID: 16258331
[TBL] [Abstract][Full Text] [Related]
29. Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection.
Sarmento-Castro R; Horta A; Vasconcelos O; Coelho H; Mendez J; Tavares AP; Seabra J; Duarte M; Chaves L; Fortes O; Recalde C; Ventura A; Pires N; Pinho L; Dias N; Carneiro F
J Infect; 2007 Jun; 54(6):609-16. PubMed ID: 17194480
[TBL] [Abstract][Full Text] [Related]
30. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Franchini M
Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
[TBL] [Abstract][Full Text] [Related]
31. Care of patients with hepatitis C and HIV co-infection.
Soriano V; Puoti M; Sulkowski M; Mauss S; Cacoub P; Cargnel A; Dieterich D; Hatzakis A; Rockstroh J
AIDS; 2004 Jan; 18(1):1-12. PubMed ID: 15090824
[No Abstract] [Full Text] [Related]
32. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
[TBL] [Abstract][Full Text] [Related]
33. Viral hepatitis and HIV: update and management.
Núñez M; Mendes-Correa MC
Antivir Ther; 2013; 18(3 Pt B):451-8. PubMed ID: 23792670
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
35. [HIV/HCV double infection: combination is a clear therapy option].
Reich B
Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
[No Abstract] [Full Text] [Related]
36. HCV/HIV co-infection therapy.
Pietrandoni G
Posit Aware; 2002; 13(2):32, 38. PubMed ID: 12004829
[No Abstract] [Full Text] [Related]
37. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
Bongiovanni M; Ranieri R; Ferrero S; Casanova F; Monforte Ad
AIDS; 2006 Oct; 20(15):1989-90. PubMed ID: 16988527
[No Abstract] [Full Text] [Related]
38. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
39. Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy.
De Bona A; Galli L; Gallotta G; Guzzo A; Alagna L; Lazzarin A; Uberti-Foppa C
New Microbiol; 2007 Jul; 30(3):259-64. PubMed ID: 17802905
[TBL] [Abstract][Full Text] [Related]
40. Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.
del Valle J; Mira JA; de los Santos I; López-Cortés LF; Merino D; Rivero A; Girón JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Pineda JA
AIDS; 2008 May; 22(8):923-30. PubMed ID: 18453851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
